Severity: Warning
Message: file_get_contents(https://...@pubfacts.com&api_key=b8daa3ad693db53b1410957c26c9a51b4908&a=1): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
Filename: helpers/my_audit_helper.php
Line Number: 176
Backtrace:
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 176
Function: file_get_contents
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 250
Function: simplexml_load_file_from_url
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3122
Function: getPubMedXML
File: /var/www/html/application/controllers/Detail.php
Line: 575
Function: pubMedSearch_Global
File: /var/www/html/application/controllers/Detail.php
Line: 489
Function: pubMedGetRelatedKeyword
File: /var/www/html/index.php
Line: 316
Function: require_once
Background: Obstructive vascular lesions at the terminal portion of the internal carotid arteries are thought to be the primary and essential lesions in moyamoya disease. The etiology remains unknown. To detect possible mediators of the thickened intima of moyamoya disease, we measured serum alpha-1-antitrypsin (alpha1-AT) levels and characterized the phenotype of patients with familial moyamoya disease.
Patients And Methods: Fifty-six individuals were examined, including 29 patients with moyamoya disease from 14 families. Serum alpha1-AT levels were analyzed by electroimmunoassay and genomic phenotype by isoelectric focusing.
Results: All individuals had a normal alpha1-AT phenotype. The average serum alpha1-AT level in moyamoya disease patients was significantly higher than that of normal individuals, although both were within the normal range.
Conclusions: These findings suggest that serum alpha1-AT level may be a marker, rather than an etiologic factor, indicating the progression of moyamoya disease.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s00381-003-0799-9 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!